The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.

The efficacy and safety of a proposed biosimilar and ustekinumab are similar among adults with moderate to severe plaque psoriasis.

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality ...

The company had $583.3 million in cash as of September 30th of 2024; Enough cash to fund its operations until the end of 2027 ...

psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...

Doctors may prescribe Zoryve to treat plaque psoriasis, atopic dermatitis ... Zoryve is meant to be used as a long-term treatment. If you and your doctor determine that Zoryve is safe and effectiv ...

Let’s cover five psoriasis treatments that all Black individuals with psoriasis should avoid, based on the research.

The most important thing you can do to manage psoriasis is work with a dermatologist to create a treatment plan that’s right for you. However, in addition to working with a dermatologist ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

Mizuho Securities analyst Uy Ear has maintained their bullish stance on ARQT stock, giving a Buy rating on January 13.Stay Ahead of the ...